Related
Back to Piper Jaffray Downgrades American Oriental Bioengineering (AOB) to Neutral
Back to Piper Jaffray Downgrades American Oriental Bioengineering (AOB) to Neutral
Back to Piper Jaffray Downgrades American Oriental Bioengineering (AOB) to Neutral
Back to Piper Jaffray Downgrades American Oriental Bioengineering (AOB) to Neutral
at Aug 12, 2008 07:42 PM Adam There seemed to be allot of nervous people and nothing really getting explained. I agree that something made me not trust them. I see no real reason for them to buy this instead of a real drug company. Is this new company they waisted all that money on related to AOB CEO?
at Aug 12, 2008 02:15 PM Great Call!!??LOL.. Pj.. should re read earnings and listen CC again.. or see a Doc..
at Aug 12, 2008 12:51 PM How can you not get it? Piper did call a good downgrade The big world drug companies have already learned:Its not adding more drup reps that bring in major sales, its adding a better product to your line. AOB sells basically the same things other China companies sell. How could you not get it?
at Aug 12, 2008 12:41 PM Deserved downgrade Something is really starting to smell with AOB. This latest action by them seems like it is being done so they can cover up a loose money trail.
at Aug 12, 2008 12:37 PM Don't get it Piper handled the failed offering several months ago, and was replace by Merrill as manager of the second offering. Sore losers. This is a new analyst for Piper who does not seem to understand the implications of this acquisition, as most acquisitions have not been understood. This history of acquisitions by AOB is that they have made very good judgments, have gained a very considerable return from them, and they know the market far better than Piper does. This acquisition will have a significant growth impact on all of AOBs businesses, increase margins and return from those, give them leverage for future acquisitions bycontrolling distribution channels, and greatly increase revenue, although margins will come down as a result of this type of business. But, net return to shareholders on the 110m should be good.
at Aug 12, 2008 12:30 PM AOB Bad call. AOB is growing to much for this downgrade. The new distributor is already profitable and will only help AOB.
at Aug 12, 2008 12:00 PM What Pipe Are They Smoking at Piper They are getting bigger & more proftible & its bad. Brilliant.
at Aug 12, 2008 11:26 AM aob downgrade Completely miss guided. This company has a huge amount of cash and there is no dilution involved with the purchase of the distributor. Sounds like alot of guessing on Piper Jaffray's part. You so called analysts are nothing but Wall Street Crooks and you know it.